JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valette, H.
Right arrow Articles by Crouzel, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valette, H.
Right arrow Articles by Crouzel, C.

In Vivo Quantification of Myocardial Dihydropyridine Binding Sites: A PET Study in Dogs

Héric Valette, MD1, Frédéric Dollé, PhD1, Ilonka Guenther, PhD1, Chantal Fuseau, BS1, Christine Coulon, BS1, Françoise Hinnen, BS1, Jean-Louis Péglion, PhD2 and Christian Crouzel, PhD1

1 Department of Medical Research, Direction of Life Sciences, Service Hospitalier Frédéric Joliot, French Atomic Agency, Orsay, France
2 Institut de Recherche Servier, Suresnes, France



View larger version (17K):

[in a new window]
 
FIGURE 1. Four-compartment ligand-receptor model used in analysis of S12968 time-concentration curves obtained with PET. All transfer probabilities of ligand between compartments are linear, except binding probability, which depends on local association rate constant (kon), local free ligand concentration (M*f(t)/VR), and local concentration of receptor sites (Bmax - M*b(t)). PET experimental data correspond to sum of labeled ligand in 3 tissue compartments and in fraction FV of blood concentration. M*ns(t) = nonspecifically bound radioligand.

 


View larger version (13K):

[in a new window]
 
FIGURE 2. PET left ventricular time-activity curve after injection of 9.9-nmol dose of 11C-S12968, followed 20 min later by injection of 8.8 nmol, followed 20 min later by injection of 10.1 nmol. Time-activity curve is characterized by low noise contribution. Quality of fit of experimental data to 3-compartment mathematic model is satisfactory. DATA = data from experiment 3; MODEL = 3-compartment mathematic model.

 


View larger version (9K):

[in a new window]
 
FIGURE 3. Relationship between injected mass of S12968 and left ventricular uptake, estimated by K1. Correlation was clearly linear.

 


View larger version (10K):

[in a new window]
 
FIGURE 4. Relationship between injected mass of S12968 and left ventricular washout, estimated by k2. Correlation was clearly linear.

 


View larger version (11K):

[in a new window]
 
FIGURE 5. Mean (experiments 3–5) and SD of unchanged 11C-S12968 in plasma, as function of time. Shape of curve remained coarsely unchanged after each of the 3 injections.

 


View larger version (17K):

[in a new window]
 
FIGURE 6. Computer simulation of S12968 kinetics during multiinjection experiment (PET data from experiment 3, as in Fig. 2). Figure shows S12968 concentration in all compartments simulated using model parameters given in Table 3: specifically bound ligand concentration and free ligand. Solid line is simulation of PET-measured S12968 concentration.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.